menu

ReachMD

Be part of the knowledge.
Register

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

Study Compares Health Care Usage, Cost in Developed Countries for Patients Dying with Cancer

    [Read the Article] To some, end of life care in the United States is considered resource intensive, expensive, and inattentive to patients' needs....
    • In Partnership with

    • Overview

      [Read the Article]

      To some, end of life care in the United States is considered resource intensive, expensive, and inattentive to patients' needs. So how does the United States compare to other countries? A new study examined several health care measures at the end of life for cancer patients in five European countries, Canada and the United States.

      Researchers from the University of Pennsylvania Perelman School of Medicine compared the health care experience for cancer patients older than 65, in Canada, Belgium, Germany, England, the Netherlands, Norway and the United States. They examined several clinical measures during the final six months of life.

      The United States and Netherlands had the lowest percentage of patients dying in the hospital. The United States also had the fewest hospitalizations and the smallest number of days patients spent in the hospital. In contrast, intensive care admissions were twice as common in the United States compared to the other countries. 

      During the last six months of life, patients in Norway and Canada had higher hospital costs than patients in the United States. There was less spending in Germany and Belgium, but the lowest expenditures were in the Netherlands and England.

      [Watch more videos of The JAMA Report]

    Facebook Comments

    LIVE ON REACHMD RADIOBack to live radio
    ReachMD Radio

    Loading...

    00:00
    00:00

      You must be in to display playlists.

      Get a Dose of ReachMD in Your Inbox
      and Practice Smarter Medicine

      Stay current with the best in medical education.